F. Huguet

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib

Pascal Hammel, F. Huguet, Jean‐Luc Van Laethem et al. · JAMA · 2016 · 1.1K citations

Medicine, Oncology, Pharmacology +13

Biliary cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Juan W. Valle, Ivan Borbath, Shahid A. Khan et al. · Annals of Oncology · 2016 · 687 citations · Full text

Medicine, Oncology, Surgery +14

Impact of Chemoradiotherapy After Disease Control With Chemotherapy in Locally Advanced Pancreatic Adenocarcinoma in GERCOR Phase II and III Studies

F. Huguet, Thierry André, Pascal Hammel et al. · Journal of Clinical Oncology · 2007 · 536 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

J. Guigay, Anne Aupérin, Jérôme Fayette et al. · The Lancet Oncology · 2021 · 232 citations

Medicine, Oncology, Chemotherapy +14

HIV-Specific Differences in Outcome of Squamous Cell Carcinoma of the Anal Canal: A Multicentric Cohort Study of HIV-Positive Patients Receiving Highly Active Antiretroviral Therapy

Christoph Oehler‐Jänne, F. Huguet, Sawyna Provencher et al. · Journal of Clinical Oncology · 2008 · 204 citations

Medicine, Oncology, Radiation Oncology +14